Canaccord Genuity analyst John Newman maintains his Buy rating and price target of $85 on Radius Health Inc (NASDAQ: RDUS).
Latest Ratings for RDUS
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 2017 | Cowen & Co. | Downgrades | Outperform | Market Perform |
| Mar 2017 | H.C. Wainwright | Reiterates | Buy | |
| May 2016 | H.C. Wainwright | Initiates Coverage on | Buy |
View More Analyst Ratings for RDUS
View the Latest Analyst Ratings
May 22, 2017 at 06:52PM
from Merrick Weingarten
No comments:
Post a Comment